Two Sigma Advisers
PNT

Two Sigma Advisers’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Two Sigma Advisers’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20,200
Closed -$135K – 2685
2023
Q3 		$135K Sell
20,200
-142,500
-88% -$1.18M ﹤0.01% 2165
2023
Q2 		$1.47M Buy
162,700
+111,500
+218% +$983K ﹤0.01% 1358
2023
Q1 		$372K Buy
+51,200
New +$380K ﹤0.01% 2059

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Two Sigma Advisers's PNT Position: Q4 2023 in Review

Two Sigma Advisers sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 20,200 shares — an estimated $135K sold.

Two Sigma Advisers first reported a position in PNT in Q1 2023 and held it in 3 quarters. The position peaked at $1.47M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Two Sigma Advisers reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 20,200 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $135K.
  • Two Sigma Advisers first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Two Sigma Advisers's POINT Biopharma Global Inc. Common Stock position peaked at $1.47M in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Two Sigma Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.